{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-25-001033","form_type":"8-K","ticker":"AVXL","cik":"0001314052","company_name":"ANAVEX LIFE SCIENCES CORP.","filed_at":"2025-07-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.631423+00:00","generated_at":"2026-05-18T00:09:29.072916+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Anavex Life Sciences enters $150M at-the-market equity facility with TD Securities","bullets":["Sales agreement with TD Securities (USA) LLC for ATM offering of up to $150M in common stock.","Shares sold under shelf registration statement filed July 14, 2025, effective July 23, 2025.","Sales agent commission up to 3.0% of gross proceeds; company not obligated to sell any shares.","Sales may be conducted on Nasdaq or in negotiated transactions; offering can be suspended by either party."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-25-001033","json":"https://secwatch.observer/filing/0001731122-25-001033.json","markdown":"https://secwatch.observer/filing/0001731122-25-001033.md","text":"https://secwatch.observer/filing/0001731122-25-001033.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1314052/000173112225001033/0001731122-25-001033-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1314052/000173112225001033/e6735_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T00:09:29.072916+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}